IVU has been gradually replaced over recent years as the "gold standard" investigation for the renal parenchyma and urinary tract by two new modalities: ultrasound and computed tomography. Some authors still advocate IVU for the assessment of renal colic, for the following reasons: the excess cost of CT (which is not true for plain CT) and the absence of functional data (there are specific CT signs for increased pressure). However, the advantages of CT are clearly established: contrast resolution allowing the detection of almost all stones except for certain complications of triple combination therapy in HIV seropositive patients, extensive cover facilitating identification of differential diagnoses, rapidity and greater efficacy, and finally the absence of risk related to the injection of iodinated contrast agents in this indication. However, the performance of CT may be more limited in certain situations: thin patients, or when the female genital tract also needs to be investigated, but IVU is not more contributive in this context. The current place of IVU in renal colic is therefore to establish a definitive diagnosis and to guide an urgent procedure (removal of an obstruction in a context of infection) when CT is either unavailable (maintenance...) or really excessively irradiating, as in pregnant women, when ultrasound, or even MRI and MR urography have not been sufficiently contributive. The essential indication remains detailed visualization of the urinary tract (assessment of haematuria, detection of an urothelial tumour), detailed visualization of the entire urinary tract (assessment of certain malformations), or even a gross assessment of renal function in a patient with multiple injuries, which cannot be investigated by CT and in whom the surgeon rightly hesitates before opening the retroperitoneum. However, in the absence of IVU, we may fail to diagnose papillary necrosis or a small caliceal diverticulum, but is that really important in the final analysis? IVU, in countries with adapted equipment, is therefore now only an expert examination. IVU is an examination of the past, without a future indeed, but with a descendant: CT urography.
Download full-text PDF |
Source |
---|
Int Urol Nephrol
January 2025
Department of Colorectal Surgery, Heliopolis Hospital, São Paulo, SP, Brazil.
Purpose: Locally advanced colorectal tumors frequently invade adjacent organs, particularly the urinary bladder in the sigmoid colon and upper rectum, complicating multivisceral resections. This study compared postoperative outcomes of partial cystectomy (PC) and total cystectomy (TC) in patients with locally advanced colorectal cancer.
Methods: A systematic review was conducted in PubMed, Scopus, Central Register of Clinical Trials, and Web of Science for studies published up to November 2024.
BJU Int
January 2025
Department of Obstetrics and Gynecology, Herlev and Gentofte University Hospital, Herlev, Denmark.
Objectives: To evaluate the effect of intravesical alkalinised lidocaine as an anaesthetic treatment on procedural pain during intradetrusor onabotulinumtoxinA (BTX-A) injections for overactive bladder.
Patients And Methods: This single-centre, randomised, double-blind, placebo-controlled two period crossover trial was conducted on women scheduled for BTX-A injections at our outpatient urogynaecology clinic between September 2022 and May 2024. Patients were randomly assigned (1:1) to receive either alkalinised lidocaine or placebo during the first treatment period.
Nephrology (Carlton)
January 2025
Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
The case report presents a male patient in his mid-60s with a history of hypertension, benign prostatic hyperplasia and chronic kidney disease (CKD). He presented with gradually increasing serum creatinine levels and hyperglobulinemia, leading to suspicion of multiple myeloma. However, subsequent testing revealed features consistent with systemic lupus erythematosus (SLE) and IgG4-related kidney disease (IgG4-RKD).
View Article and Find Full Text PDFActa Physiol (Oxf)
February 2025
Department of Medicine, Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland.
Aim: Proteinuria is the most robust predictive factors for the progression of chronic kidney disease (CKD), and interventions targeting proteinuria reduction have shown to be the most effective nephroprotective treatments to date. While glomerular dysfunction is the primary source of proteinuria, its consequences extend beyond the glomerulus and have a profound impact on tubular epithelial cells. Indeed, proteinuria induces notable phenotypic changes in tubular epithelial cells and plays a crucial role in driving CKD progression.
View Article and Find Full Text PDFJ Clin Med
January 2025
2nd Chair and Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.
Genitourinary Syndrome of Menopause (GSM) is a prevalent condition in postmenopausal women characterized by symptoms such as vaginal dryness, itching, and urinary tract issues due to declining estrogen levels. Despite its widespread impact on quality of life, GSM often remains underdiagnosed and without effective treatment. This study assessed the long-term efficacy of fractional CO laser treatment in alleviating GSM symptoms in perimenopausal women.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!